WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Validation and Implementation Design of an Epic Systems 30-day Unplanned Readmission Risk Model

Not Applicable

Completed

Conditions: Patients at High Risk of Unplanned Readmission
Unplanned Hospital Readmissions

Interventions: Behavioral: Epic 30-day unplanned readmission risk score

First Posted Date: 2022-06-10

Last Posted Date: 2023-12-29

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 68

Registration Number: NCT05413889

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis

Phase 2

Not yet recruiting

Conditions: Cystic Fibrosis
Abdominal Pain
Small Bowel Disease

Interventions: Drug: Rifaximin 550 MG Oral Tablet [XIFAXAN]
Drug: Placebo

First Posted Date: 2022-06-07

Last Posted Date: 2024-11-25

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 100

Registration Number: NCT05408910

Locations: 🇺🇸
Atrium Health, Charlotte, North Carolina, United States

Radiofrequency Hyperthermia Safety Study

Not Applicable

Completed

Conditions: Soft Tissue Injuries
Chronic Pain
Wound Heal
Blood Flow

Interventions: Device: Laser Doppler
Device: Radiofrequency Heating System
Device: Thermal Imaging
Other: Healthcare Questionnaire & Measurement

First Posted Date: 2022-06-01

Last Posted Date: 2024-05-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 20

Registration Number: NCT05399771

Locations: 🇺🇸
Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States

Autologous Muscle Fiber Fragment Injections

Not Applicable

Recruiting

Conditions: Fecal Incontinence

Interventions: Procedure: Muscle Fiber Fragment (MFF) Injections

First Posted Date: 2022-05-31

Last Posted Date: 2024-04-25

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 10

Registration Number: NCT05396456

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Mastectomy Flap Temperature Study

Not Applicable

Terminated

Conditions: Mastectomy
Breast Cancer

Interventions: Other: Myocardial Probe Temperature Screen
Other: Data Collection

First Posted Date: 2022-05-27

Last Posted Date: 2024-12-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 19

Registration Number: NCT05395936

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Improving Disease Severity

Not Applicable

Active, not recruiting

Conditions: Psoriasis
Alopecia Areata
Polymorphous Light Eruption

Interventions: Other: Lumiton yarn shirt
Other: Lumiton yarn sleeve
Other: Lumiton yarn hat

First Posted Date: 2022-05-25

Last Posted Date: 2024-08-02

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 13

Registration Number: NCT05391178

Locations: 🇺🇸
Wake Forest University Health Sciences, Dermatology, Winston-Salem, North Carolina, United States

RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients

Phase 4

Terminated

Conditions: Photoaging
Carbon Dioxide Laser

Interventions: Drug: ReCell

First Posted Date: 2022-05-23

Last Posted Date: 2024-08-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1

Registration Number: NCT05386368

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Cognitive Behavioral Therapy (CBT) for Late Life Anxiety

Not Applicable

Withdrawn

Conditions: Generalized Anxiety Disorder

Interventions: Behavioral: Cognitive Behavioral Therapy (CBT)

First Posted Date: 2022-05-18

Last Posted Date: 2024-05-08

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT05380115

Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma

Recruiting

Conditions: Cachexia
Pancreas Adenocarcinoma

First Posted Date: 2022-05-17

Last Posted Date: 2024-07-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 100

Registration Number: NCT05376592

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss

Phase 2

Withdrawn

Conditions: Recurrent Pregnancy Loss Without Current Pregnancy

Interventions: Drug: Progesterone Pill
Drug: hCG

First Posted Date: 2022-05-09

Last Posted Date: 2022-05-09

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT05365464

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy